The Oncology Institute, Inc. – NASDAQ:TOI
The Oncology Institute stock price today
$3.929
+3.61
+1141.39%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
The Oncology Institute stock price monthly change
-32.55%
month
The Oncology Institute stock price quarterly change
-32.55%
quarter
The Oncology Institute stock price yearly change
-84.38%
year
The Oncology Institute key metrics
Market Cap | 14.93M |
Enterprise value | 142.85M |
P/E | -3.04 |
EV/Sales | 0.56 |
EV/EBITDA | 13.67 |
Price/Sales | 0.19 |
Price/Book | 0.39 |
PEG ratio | -0.02 |
EPS | -0.89 |
Revenue | 342.71M |
EBITDA | -54.55M |
Income | -65.90M |
Revenue Q/Q | 24.24% |
Revenue Y/Y | 25.29% |
Profit margin | 0.66% |
Oper. margin | -31.67% |
Gross margin | 33.81% |
EBIT margin | -31.67% |
EBITDA margin | -15.92% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThe Oncology Institute stock price history
The Oncology Institute stock forecast
The Oncology Institute financial statements
| Jun 2023 | 80.22M | -16.89M | -21.06% |
|---|---|---|---|
| Sep 2023 | 82.03M | -17.41M | -21.23% |
| Dec 2023 | 85.78M | -15.31M | -17.85% |
| Mar 2024 | 94.66M | -16.27M | -17.19% |
| 2025 | 482.76M | -35.26M | -7.31% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 229959000 | 145.23M | 63.16% |
|---|---|---|---|
| Sep 2023 | 218353000 | 146.50M | 67.1% |
| Dec 2023 | 219418000 | 162.39M | 74.01% |
| Mar 2024 | 204532000 | 163.23M | 79.81% |
| Jun 2023 | -8.66M | 24.90M | -2.60M |
|---|---|---|---|
| Sep 2023 | -8.31M | 7.70M | -756K |
| Dec 2023 | -3.89M | 11.62M | -1.78M |
| Mar 2024 | -15.88M | 19.38M | -938K |
The Oncology Institute alternative data
| Sep 2023 | 750 |
|---|---|
| Oct 2023 | 750 |
| Nov 2023 | 750 |
| Dec 2023 | 750 |
| Jan 2024 | 750 |
| Feb 2024 | 750 |
| Apr 2024 | 750 |
| May 2024 | 800 |
| Jun 2024 | 800 |
| Jul 2024 | 800 |
The Oncology Institute other data
18.08%
-11.48%
of TOI is owned by hedge funds
22
-17
14.57M
-8.95M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 80000 |
| Nov 2024 | 250000 | 0 |
| Dec 2024 | 50000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | HIVELY BRAD director | Common stock | 50,000 | $0.15 | $7,500 | ||
Purchase | HIVELY BRAD director | Common stock | 250,000 | $0.17 | $42,500 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 8,637 | $2.12 | $18,310 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 6,979 | $2.14 | $14,935 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 11,882 | $2.07 | $24,596 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 24,915 | $2.3 | $57,304 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 5,338 | $2.11 | $11,263 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 10,263 | $2.12 | $21,758 | ||
Sale | HAVENCREST HEALTHCARE PARTNERS, L.P. 10 percent owner | Common stock | 11,986 | $2.13 | $25,530 | ||
Purchase | SHAH MIHIR officer: Chief Fi.. | Common stock | 565 | $1.25 | $706 |
| Quarter | Transcript |
|---|---|
| Q1 2024 18 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 10 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of The Oncology Institute stock today?
One share of The Oncology Institute stock can currently be purchased for approximately $3.93.
-
When is The Oncology Institute's next earnings date?
Unfortunately, The Oncology Institute's (TOI) next earnings date is currently unknown.
-
Does The Oncology Institute pay dividends?
No, The Oncology Institute does not pay dividends.
-
How much money does The Oncology Institute make?
The Oncology Institute has a market capitalization of 14.93M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28.42% to 324.24M US dollars.
-
What is The Oncology Institute's stock symbol?
The Oncology Institute, Inc. is traded on the NASDAQ under the ticker symbol "TOI".
-
What is The Oncology Institute's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of The Oncology Institute?
Shares of The Oncology Institute can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does The Oncology Institute have?
As Jul 2024, The Oncology Institute employs 800 workers, which is 7% more then previous quarter.
-
When The Oncology Institute went public?
The Oncology Institute, Inc. is publicly traded company for more then 5 years since IPO on 4 Jun 2020.
-
What is The Oncology Institute's official website?
The official website for The Oncology Institute is theoncologyinstitute.com.
-
Where are The Oncology Institute's headquarters?
The Oncology Institute is headquartered at 18000 Studebaker Road, Cerritos, CA.
-
How can i contact The Oncology Institute?
The Oncology Institute's mailing address is 18000 Studebaker Road, Cerritos, CA and company can be reached via phone at +213 7601328.
The Oncology Institute company profile:
The Oncology Institute, Inc.
theoncologyinstitute.comExchange:
NASDAQ
Full time employees:
800
Industry:
Medical - Care Facilities
Sector:
Healthcare
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
18000 Studebaker Road
Cerritos, CA 90703
Cerritos, CA 90703
CIK: 0001799191
ISIN: US68236X1000
CUSIP: 68236X100
